InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Burroughs Amy L., Director. Officer active across 1 companies, notably DiaMedica Therapeutics Inc.. In total, 4 filings have been logged. Total volume traded: €240k. The latest transaction was disclosed on 3 January 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations4 total
€35,19711,182 shares@ €3.147722.7% of flow
Voting Common Shares, no par value per share
SEC:0001235802-22-000004·
€35,19711,182 shares@ €3.14770.0085% mcap11.3% of flow
Voting Common Shares, no par value per share
SEC:0001235802-22-000004:0·
€120,19844,950 shares@ €2.67477.3% of flow
Voting Common Shares, no par value per share
SEC:0001235802-21-000101·
Ideal exit: 13 May 2022 (T+270)
€120,19844,950 shares@ €2.6740.029% mcap38.7% of flow
Voting Common Shares, no par value per share
SEC:0001235802-21-000101:0·
Ideal exit: 13 May 2022 (T+270)
4 of 4 declarations
About Burroughs Amy L.
Amy L. Burroughs is a Director at DiaMedica Therapeutics Inc. In this role, she participates in the governance of the company and in strategic decision-making. Her experience is valuable for guiding DiaMedica's initiatives.
